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Abstract 
Electrospun Cartilage Glycosaminoglycans for Biomimetic Scaffolds 
Sean Michael Dowd 
Caroline L. Schauer, Ph.D. 
 
 
 
 
Osteoarthritis is a condition through which cartilage is broken down by the human 
body (1).  Osteoarthritis of the knee affects approximately 84.5 million people over the 
age of 45 in the US alone, or over 27% of the entire population (1). In order to help 
combat such a debilitating condition, this study investigated electrospinning natural 
polymers that are found in human cartilage: hyaluronic acid and chondroitin sulfate.  
Polymer fibers were created using two different solvent systems: aqueous N,N - 
dimethylformamide and acetic acid. Optimization tests were performed on each sample to 
attempt to control factors such as fiber diameter and polymer concentration.  In order to 
understand which system would be better for the human body, crosslinking and solubility 
studies were performed.  When attempting to spin, it was discovered that only the 
solution containing aqueous N,N – dimethylformamide and an excess of HA could be 
successfully be electrospun and crosslinked.  
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Chapter 1: Introduction 
1.1 Materials 
1.1.1 Overview of Glycosaminoglycans 
 Glycosaminoglycans (GAGs), linear polymers consisting of two repeating 
disaccharide units, are an important part of human physiology (2).  These units are 
always consist of an amino-sugar and uronic acid.  Occasionally, a galactose unit will be 
seen in place of one of the other two (2).  In mammals, virtually every cell produces at 
least one GAG in order to provide support to the extra-cellular matrix (ECM) allowing 
the cells to hold together (2).  To use an analogy to everyday life, GAGs are the glue that 
holds the body’s cells together.   
Both human cartilage and meniscus have large quantities of two GAGs: 
chondroitin sulfate (ChS) and hyaluronic acid, also known as hyaluronan or hyaluronate 
(HA) (1, 3) .  These GAGs are essential parts of the cartilage and meniscus.  Specifically, 
ChS and HA are responsible for most of the chemical bonding that takes place within the 
tissue (1, 4–6).   
1.1.2 Challenges of Using Glycosaminoglycans 
 As GAGs are a form of biopolymers, there are several complications that must be 
dealt with in order for them to be used.  For example, GAGs, and other biopolymers can 
have different molecular weights (MW), purity, charge distribution, and even structure 
depending on the source (7, 8).  A good example of this is chondroitin sulfate.  
Although more detail about chondroitin sulfate will be discussed later, it is a 
perfect example of how structural differences can change the behavior of the polymer.  
Chondroitin sulfate can exist in two structural forms: chondroitin-4-sulfate or 
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chondroitin-6- sulfate (7, 9, 10).  The only difference between the two is where the 
sulfate is located (7, 9, 10).  However, this change means the loss of a primary hydroxyl 
group which can make chemical modification difficult.      
1.2 Applications 
  One of the primary applications for GAGs involves the repair of the major soft 
tissues of the human knee.  In order to fully understand these applications, however, a 
basic overview of human anatomy is required. 
1.2.1 Epidemiology of Knee Cartilage and Meniscus 
 Around the world, both cartilage and meniscus injuries are a huge problem.  
Many of these injuries are sports related, but not all.  What is particularly alarming is that 
a problem in either the meniscus, or the cartilage, can lead to damage of the other tissue 
as well. 
Meniscus injuries involve a large percentage of patients.  In the United States, 
approximately 200,000 people suffer from meniscus injury (11).  Most of these are sports 
related injuries (11).  Of these, 92% require a meniscectomy (11).  A meniscectomy is a 
surgical procedure where the patients’ own meniscus is removed (11, 12).  Furthermore, 
over many years a patient that had their meniscus removed will suffer from articular 
cartilage degradation as well at an average rate of 4% per year (1, 11, 12).  
To compound this problem is osteoarthritis (OA).  OA is a condition through 
which cartilage tissue (regardless of type) is broken down by the body (1).  OA of the 
knee affects approximately 84.5 million people over the age of 45 in the US alone, or 
over 27% of the entire population (1).  What are more horrifying are the age 
demographics.  Of the US population, 1/5 people over the age of 45 will suffer from OA, 
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as compared to 1/2 of the population over 65 that will have OA (1).  With statistics like 
these, it is clear that some sort of biomimetic material or regenerative template is needed. 
1.2.2 Cartilage Tissue Degradation 
 Cartilage due to OA is due to several issues associated with the tissue and its 
environment.  The most important factor of cartilage loss due to OA is age (13).  The age 
of the tissue allows for degradation from mechanical loading and water loss in the tissue 
(13).  As the tissues age, the collagen and a proteoglycan named aggrecan (see Chapter 
2.1.1)  in the tissue does not retain as much water as before (13, 14).   See Figure 1 for 
the material components of human cartilage and meniscus tissue.  This change in water 
retention is due to changes in molecular weight, concentration, and structure that will 
lead to a change in the ECM and result in lowered mechanical strength of the tissue (1, 
13, 14).  This decrease in mechanical strength and stability could allow for the tissue to 
become permanently damaged if too much stress is placed on the joint (13).  This will 
lead to a cascade effect in which more water is lost and the mechanical strength is 
decreased even more until physiologically normal stresses can cause the tissue to 
mechanically fail (13).  
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Figure 1: Material components of human meniscus.  Cartilage has a very similiar 
composition.  Image from (12). 
 
1.3 Current Non-Tissue Engineered Treatments for OA 
 As of the time of this writing, there are several clinically available or FDA 
approved methods for the treatment of OA.  As with all medical procedures, some 
treatments are for the early stages of OA, while others are intended for late-stage OA.  
Three of the major treatment options will be discussed here.  They are the injection of 
GAGs into the intra-articular cavity, a meniscectomy, and the use of an on the market 
biomimetic material. 
 One of the more common treatments on the market is the direct injection of HA 
into the OA site.  This treatment works on the principle that since HA is a natural 
component of the cartilage in this area, a direct injection should help to rejuvenate the 
amount of HA that is available for the cartilage to use to heal itself (15, 16).  As one 
author noted: 
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“HA has a variety of effects on cells in vitro that may relate to its reported 
effects on joint disease. For example, it inhibits prostaglandin E2 synthesis 
induced by interleukin-1 (IL-1); protects against proteoglycan depletion and 
cytotoxicity induced by oxygen-derived free radicals, IL-1, and mononuclear cell–
conditioned medium; and affects leukocyte adherence, proliferation, migration, 
and phagocytosis. HA has been shown to have a direct effect on control 
mechanisms of cell activation in monocytes, e.g., it increases messenger RNA 
expression for IL-1b, tumor necrosis factor a (TNFa), and insulin-like growth 
factor 1 (IGF-1). Monoclonal antibodies against the HA receptor, CD44, block 
the effect of HA on expression of IL-1b, TNFa, and IGF-1, indicating direct 
interaction of HA with the cell. In cartilage, HA has been shown to suppress 
cartilage matrix degradation by fibronectin fragments (15).” 
Additionally, since the treatment was made clinically available, it has been discovered 
that direct injections of HA may help to inhibit the progress of OA all together (15).   
This treatment has been in use for several decades, but there are still numerous 
issues with this treatment.  To begin, many studies that compared the injection of HA to 
the injection of a placebo have shown that there is little statistical difference between the 
two (15, 16).  Furthermore, there is still little evidence that the treatment is effective in 
humans (15, 16).  Both of these issues are huge weaknesses that must be addressed. 
 One of the oldest, and still most common, treatments for OA is a meniscectomy.  
This is the surgical removal of the meniscus tissue (11, 12).   A meniscectomy is 
performed when a surgeon has determined that the meniscus has taken too much damage, 
and that the removal of the meniscus is the only way to help alleviate some pain (11, 12).  
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This treatment has existed for nearly a century, but is beginning to die out (12).  As early 
as 1948, it was discovered that the complete removal of the meniscus would lead to 
adhervse, and possibly worse conditions in the patient’s knee (12).  As a result, most 
surgeons have begun to move away from this treatment in favor only partially removed 
the meniscus tissue or attempting to repair the tissue (11, 12).   
 Needless to say, the complete removal of a patient’s meniscus is a completely 
unacceptable treatment.  The meniscus is an essential component of the knee, and it must 
be preserved as much as possible.  Without it, the knee joint would not be able to 
withstand the compressive forces that it experiences on a daily basis. 
 Finally, a relatively new treatment that was released on the market that may yet 
alter the way meniscus and cartilage conditions are treated in the knee.  The product 
name is Menaflex®.  Menaflex® was a collagen based implant that was either a 
biomimetic that served in place of a functional meniscus, or a platform for tissue 
regeneration (17, 18).  This ambiguity is exactly what caused the US Food and Drug 
Administration (FDA) to rescind its previous clearance for the device, and ban its use in 
the US (17, 18).  As a result, the company that sold the product went bankrupt and, 
unfortunately, little data is available in regard to Menaflex® aside from information listed 
in the legal briefs surrounding the lawsuits concerning the FDA’s actions (17, 18).   
1.4 Tissue Engineered Treatments 
 One of the most heavily researched areas for the treatment of OA is tissue 
engineering.  Tissue engineering is the development of a bio-compatible scaffold that is 
loaded with the appropriate cells types for the target tissue (19).  The cartilage types in 
the knee are ideal for tissue engineered devices because they have poor natural 
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regenerative ability (19).  See Figure 2 for a basic schematic for tissue engineered 
cartilage. 
 
Figure 2: Techniques for cartilage tissue engineering.  Image taken from (19). 
  
The tissue engineering approach to treating OA is a comparatively new 
development. As mentioned above, tissue engineering requires the development of a 
biocompatible scaffold in addition to the correct cells types for the targeted tissue.  As 
can be seen in Table 1, several materials have already been evaluated for use for tissue 
engineered cartilage, included both HA and ChS.   
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Table 1: Scaffolds that have been developed for tissue engineering applications for 
human cartilage. Compiled from (19). 
 
Scaffolds Hydrogel Available 
Proteic scaffolds 
Collagen Yes 
Gelatin No 
Fibrin Yes 
Polysaccharidic scaffolds 
Alginate Yes 
Cellulose Yes 
Chitosan Yes 
Hyaluronic Acid Yes 
Chondroitin Sulfate Yes 
Artificial scaffolds 
Carbon fiber No 
Calcium phosphate No 
Dacron® No 
Polyethylmethacrylate Yes 
Polyglycolic acid Yes 
Polylactic acid No 
Teflon ® No 
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1.5 Overview of Knee Cartilage and Meniscus Anatomy 
1.5.1 Articular Cartilage 
 Articular cartilage  is defined as the type of hyaline cartilage that is present on the 
ends of all of the bones in the knee (see Figure 3) (1).  This tissue provides cushioning for 
the bone from mechanical  forces (1).  
 
 
 
 
Figure 3: The location of articular cartilage in the knee.  The most prominent area is 
seen in this image.  The white area on the femur is an area of articular cartilage.  Taken 
from (11). 
 
 
 
Hyaline cartilage has very unique properties due to its structure.  The structure is 
comprised of three layers of organization: the superficial zone, the middle zone, and the 
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deep zone (1).  The superficial zone is comprised of collage fibers that are aligned 
parallel to the surface of the cartilage (1).  This zone occupies approximately 10-20% of 
the total tissue (1).  The middle zone occupies 40-60% of the tissue is is comprised of 
collagen fibers in a random formation (1).  Finally, the deep zone consists of the 
remaining tissue and contains fibers that are parallel to the surface of the tissue (1).  This 
behavior can be seen in Figure 4.  What really affects the mechanical properties of the 
hyaline cartilage is the collagen.  The collagen types that are present are type II (over 
50% dry weight of the tissue),V, VI, IX, and XI (1).  These collagen types have 
extremely high mechanically strength (1). 
 
 
   
 
Figure 4: Sketch of the layers of hyaline cartilage.  The image is arranged such that the 
superficial zone is at the top, the middle zone is in the middle, and the deep zone is on the 
bottom.  The image on the left containing the circular shapes indicates the orientation of 
the cells.  The middle image shows the alignment of the collagen fibers.  The right image 
is a false color image of human hyaline cartilage.  Image taken from (1). 
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1.5.2 Meniscus 
 The meniscus is a U-shaped tissue that is located between the femur and tibia (see 
Figure 5) (3, 11, 12).  The meniscus provides balance in the knee and transfer mechanical 
loads in the joint (3, 11, 12).  There are two menisci in each knee in the medial and lateral 
directions (3, 11, 12).  Given its mechanical function, the meniscus must be able to 
withstand many mechanical forces. 
 
 
 
 
Figure 5: Image of the meniscus.  The colored areas refer to the amount of 
vascularization in the tissue.  The reddest are the most vascularized, while the white 
areas are avascularized.  Image taken from (12). 
 
 
 
Not surprisingly, meniscus tissue is not very different from the articular cartilage.  
In fact, the meniscus is a a type of cartilage known as fibrocartilage (3, 11).  
Fibrocartilage has similar properties to hyaline, but it has a different structure.  As the 
name suggests, fibrocartilage consists of a fibrous structure (12).  Due to its similarity to 
hyaline cartilage, the meniscus can support a lot of force. 
12 
 
 
The mechanical properties of the meniscus are also due to its structure and 
materials.  The meniscus is composed of three layers: superficial, lamellar, and deep (3, 
11, 12).     Collagen fibers in the superficial and lamellar regions are randomly orientated 
(3, 12).  The deep zone of the meniscus is comprised of ordered fibers that run parallel to 
the surface of the meniscus (3, 12).  See Figure 6 for a pictorial example of the fiber 
orientation and locations. The top two layers of the meniscus are comprised of elastic like 
collagen type I, while the deep zone is comprised of mostly collagen type II (12).  This 
mix of flexible and rigid collagen types explain how the menisci can handle both the 
weight of the individual, and endure all the physical activity that the individual performs. 
 
 
 
 
Figure 6: Arrangement of the fiber orientations within the meniscus, and their location.  
Image taken from (12). 
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1.6 Overall Goal and Objectives 
1.6.1 Overall Goal 
 The overall goal of this study was to electrospin chondroitin sulfate and 
hyaluronic acid in such a manner that the natural anatomy of cartilage tissue was 
mimicked.  This will lay the groundwork for a device that could be used in an 
implantable device to replace either articular cartilage or meniscus.   
For articular cartilage, the device will have varying dimensions.  This is due to the 
amount of degradation that can be variable from patient to patient (1).  However, one 
constant is that the thickness of the mimicked articular cartilage should be 2.26 ± 0.49 
mm (20).     
For the meniscus tissue, the dimensions are more quantifiable.  The dimensions 
do vary depending on which of the two meniscus locations is being targeted, the sex of 
the patient, the age, and the activity level (12).  Targeted dimensions for a device for the 
medial meniscus should be 40.5 – 45.5 mm in length, and 27 mm in width (12).  For the 
lateral meniscus, length should be 32.4 – 35.7 mm and the width  should be 26.6 – 29.3 
mm (12).  Furthermore, the circumferential dimension for the medial meniscus should be 
approximately 90 – 110 mm, but the circumferential dimension for the lateral meniscus it 
should be 80 – 100 mm (12).   
1.6.2 Objectives 
 The objectives of this study are three-fold.  First, an optimization study of an 
aqueous N,N - dimethylformamide system will be performed (see Chapter 2.1.3).  This 
study was based on work from previous researchers (21, 22).  Secondly, the use of a 
solvent system that is considered to be safer to the human body, acetic acid, will be will 
be used to create electrospun fiber.  Finally, the chemical stability of the aforementioned 
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electrospun mats will be examined through the crosslinking of the mats and solubility 
testing. 
 In short, it is believed that the electrospun and crosslinked GAGs will form a 
biomimetic or regeneration template that can be used by orthopedic surgeons.  
Furthermore, this device should be simple enough that future researchers will be able to 
use this device as a starting point for the attachment of collagen and growth factors to 
encourage tissue regeneration.    
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Chapter 2: Background 
2.1 Materials 
2.1.1 Chondroitin Sulfate 
 ChS is the most important GAG in both the cartilage and the meniscus.  There are 
two types of ChS found in these tissues; they are chondroitin-4-sulfate and chondroitin-6-
sulfate (see Figure 7 for structure) (1, 6, 9).  Both forms play a huge role within aggrecan 
in cartilage (1, 6, 23).  The molecular weight of chondroitin sulfate is 50,000 (24). 
 
 
 
 
Figure 7: Image of chondroitin-4-sulfate. 
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ChS is part of a proteoglycan called aggrecan (1, 6, 9, 23).  Aggrecan, like most 
proteoglycans, is comprised of two parts: one part is a protein, and the other is a 
polysaccride (see Figure 8 for structure), and its main role is to act as a structural protein 
(1, 6).  Over 90% of aggrecan’s mass is comprised of chondroitin sulfate and its close 
relative keratin sulfate (6).  Aggrecan is essentially a brittle-brush style polymer, with the 
ChS acting as the brush (6).  There can be up to 100 individual ChS chains on each 
aggrecan molecule (20 kDa each) (6).  The ChS mainly acts an attachment site.  Collagen 
and HA attach to the ChS, and this allows the aggrecan to perform its role as a structural 
proteoglycan.  More importantly, aggrecan can absorb up to 50 times its own weight in 
water gives the cartilage tissue mechanical stability (6, 14). 
 
 
 
 
Figure 8: Structure of aggrecan.  This image contains keratin sulfate in addition to ChS.  
The “G” numbers refer to globular domains of the protein.  Taken from (6). 
 
 
 
 As briefly described earlier, aggrecan plays a key role in OA.  As previously 
mentioned, water loss is one of the key factors of OA (13).  As the body ages, aggrecan 
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will undergo changes in its molecular weight due to the native cells not being able to 
produce the same quality and quantity aggrecan as before (1, 13, 14).  Since the aggrecan 
changes, the amount of water that aggrecan can hold decreases (6, 13, 14).  This in turn 
leads to the progression of OA (13). 
2.1.2 Hyaluronic Acid 
 
 
 
 
Figure 9: Structure of hyaluronic acid. 
 
 
 
Hyaluronic acid (HA) is another essential GAG (Figure 9).  Unlike ChS, HA acts 
as an individual molecule, and not part of a proteoglycan.  Its main role and structure are 
very similar to ChS.  In hyaline cartilage, HA acts as a structural component connecting 
the aggrecan and collagen together (4, 6, 25).  Additionally, HA is responsible for cellular 
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signaling and wound healing in this tissue (4, 21, 25).  Needless to say, it is not a part of 
an essential proteoglycan, but it is essential for cartilage tissue. 
2.1.3 Solvents 
 
 
 
 
Figure 10: Structures of dimethylformamide (right) and acetic acid (left).   
 
 
 
GAGs such as HA and ChS are fairly easy to solubilize.  Both ChS and HA are 
extremely hydrophilic and will dissolve in water rapidly (5, 21, 25).  However, water is 
not the only solvent that can dissolve these GAGs.  Many aqueous organic solvents can 
also dissolve ChS and HA.  Several studies have shown that both HA and ChS can be 
dissolved using a combination of distilled water and N,N - dimethylformamide (DMF) 
(21, 22, 26–30).    DMF can be toxic to the environment, but a study has shown that the 
DMF can evaporate out of electrospun fibers (see Chapter 2.2) (31).  Furthermore, both 
ChS and HA have been shown to be able to dissolve in acetic acid (AA) (32, 33).  AA 
can also be toxic, but it has a high vapor pressure and will evaporate at room temperature 
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and low pressure (34–36).  The chemical structures for both DMF and AA can be seen in 
Figure 10. 
2.1.4 Crosslinking 
 Crosslinking is the process of chemically bonding at least two polymer chains 
together (37).  For GAGs and similar biopolymers, there are numerous crosslinking 
agents that could be used.  These include, but are not limited to genipin, epichlorohydrin, 
glutaraldehyde, and hexamethylene-1,6-diaminocarboxysulphonate (38–44).  Ideally, a 
crosslinker should be water soluble, nontoxic, and cost-effective (45).  One crosslinking 
agent that comes comparatively close to this description is divinyl sulfone (DVS).  DVS 
has been used many times in the past to crosslink polymers that contain primary hydroxyl 
groups (45–47).  In addition to the above qualities, one upside to using DVS is that its 
unique sulfone group can be detected using sulfur microanalysis (45).  In short, compared 
to other crosslinkers, DVS is very easy to identify.   
 The mechanism of reaction for DVS is simple.  DVS crosslinks via a modified 
form of a 1,4 addition, also known as a Michael addition (45).  In the most general form, 
a Michael addition is a reaction in which a carbanion undergoes a conjugate addition to a 
carbonyl compound (48).  The general form, however, is not what describes the DVS 
crosslinking reaction.  As can be seen in Figure 11, the vinyl groups on the DVS 
molecule prefer to attack primary hydroxyl groups in alkaline environments (45).     
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Figure 11: Mechanism of reaction for DVS. 
 
 
 
2.2 Electrospinning 
 Electrospinning was chosen as the primary processing technique for the proposed 
device.  This was chosen for several reasons.  The first is that electrospinning can 
produce fibrous structures similar to natural cartilage tissue, and produce the fibers in a 
low-cost way (21, 49, 50).  Secondly, electrospinning can produce fibers that are an ideal 
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diameter for a biomimetic device.  Specifically, a fiber diameter of 0.5 – 2 μm would be 
ideal for such an application (51–53). 
2.2.1 Overview of Electrospinning 
Electrospinning was first developed in the early part of the twentieth century, with 
the first US patent being awarded in 1934 to Anton Formhals (54, 55).  Electrospinning is 
a process where electrostatic forces are applied to a polymeric solution or melt for the 
fabrication of nanofibers (fibers with diameters less than 100 nm) (54).   
This simple process is flexible, scalable and cost-effective (54).  The basic 
components of an electrospinning set-up are a high-voltage electrical supply, an infusion 
pump, a collector, and of course a container for the polymeric solution with a thin 
capillary to serve as a spinneret (8, 54, 56).  An example of how a typical electrospinning 
set-up appears can be seen in Figure 12. 
 
 
 
 
Figure 12: Basic electrospinning set-ups.  Image from (54).   
 
 
 
The process is fairly simple.  First, the polymer solution or melt is loaded into a 
syringe pump with a small capillary at one end (54, 56, 57).  Next, an electrical charge is 
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applied to the solution via an electrode that is connected to the voltage supply (54, 56, 
57).  At the same time, the collector (usually a flat plate) is charged, but with the opposite 
charge of the solution (54, 56, 57).  This collector is placed at a pre-determined distance 
from the edge of the capillary (54, 56, 57).  As both the polymer and collection plate are 
oppositely charged, and since only the polymer is capable of movement, it is the natural 
tendency of the now electrically charged polymer to attempt to complete the created 
electric circuit (54, 56, 57).  The charged polymer will attempt to travel toward the plate, 
and as a result, the polymer cone at the end of the capillary form a Taylor cone from 
which jets of polymer will begin to eject from tip of the capillary (54, 56, 57). 
The jets will spin in the air until they have reached the plate (54).  All the while, 
the polymer jet will continue to become thinner and thinner due to the increased strain on 
the jet, and the solvents that were in solution with the polymer will evaporate off (54).  
When the polymer jets finally land on the plate they are extremely small in diameter (54). 
2.2.2 Parameters for Electrospinning 
 As with most manufactured items, there are several parameters that must be met 
in order to use the process effectively.  As can be seen in Figure 13, these parameters can 
be broadly broken up into three different categories.  For the purposes of this study, 
however, the parameters will be re-categorized.  Specifically, the parameters of the 
solution, the electrospinning machinery, and environmental conditions will be examined. 
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Figure 13: Common electrospinning parameters (58). 
 
 
 
2.2.2.1 Solution Parameters 
 There are several properties of the solution that can affect the quality and quantity 
of fibers produced.  Several of these properties can be adjusted, but most should be taken 
into consideration before attempting a spin.  They are viscosity, conductivity, and 
concentration. 
 Viscosity, and closely related elasticity, is one of the most important 
electrospinning parameters.  In terms of solution properties, it is the viscosity of the 
solution that determines whether or not a jet will form off of the droplet at the end of the 
capillary (8, 56, 59).  Specifically, the viscosity parameter affects the critical 
entanglement, or concentration, that will determine if a solution will electrospin 
successfully (60, 61).  Critical entanglement is the concentration where the polymer 
chains in solution begin to overlap each other and become more entwined (60–62).  As a 
result, this entanglement will cause a bending instability in the fibers, and this is what 
causes the polymer jet to whip around during the electrospinning process (60, 61).   
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Needless to say, the viscosity is an essential property to understand.  The type of 
viscosity that must be known is the relative viscosity.  This is because the relative 
viscosity that determines the fiber diameter and the morphology of electrospun fibers 
(63).  If the viscosity is too high then the solution will not be able to spin (56).  
Interestingly enough, if the viscosity is too low then it still will not spin (56).  Rather, a 
balance must be reached in order to optimize fiber production for a solution to spin.  
Unfortunately, given that every polymer solution is different, there are no set guidelines 
or recommendations in terms of desired viscosity for electrospinning  
 Another parameter of note is the electrical conductivity of the solution.  As the 
name “electrospinning” implies, the solution must be able to carry an electric current if it 
is to spin successfully (54–57).  However, much like viscosity, there is no real guideline 
for what is to be considered a “good” conductivity reading for electrospinning a solution 
(56).  What is certain is that the solution must be conductive, or else electrospinning will 
not occur. 
 Finally, the concentration of a solution can affect how well a solution will spin.  
Concentration generally ties in closely with viscosity, in that an increased concentration 
usually means an increased viscosity (56, 57, 59).  This is not always the case however.  
Several studies have shown that the concentration of the individual components of a 
solution can be modified and have various effects on the viscosity (56, 57).  More 
specifically, there appears to be an inverse relationship between concetration and fiber 
diameter size.  One study showed that a decrease in concentration led to an increase in 
fiber diameters (57).  This study was performed while examining the effects of viscosity, 
but instead the researchers stumbled across an interesting behavior concerning the 
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concentration. This further implies the underlying importance of taking concentration 
into consideration when attempting to electrospin a solution. 
 2.2.2.2 Electrospinning Parameters 
 It comes as no surprise that the electrospinning equipment can affect how well a 
solution will spin, or if it will spin at all.  As alluded to previously, there are three 
parameters that can be changed easily by just adjusting the various components of the 
electrospinning set-up.  Those parameters are target distance, accelerating voltage, and 
pump rate. 
 The distance between the capillary and collector is an important part of 
electrospinning.  Distances in the centimeter to millimeter range usually yield more 
oriented fibers (56).  However, once again there are no set guidelines for how close a 
sample should be (56).  Furthermore, the distance can actually be determined by the 
accelerating voltage because a higher voltage at a close distance could result in electrical 
damage to the sample (56). 
 As it has been made clear, the accelerating voltage is one of the most important 
parts that can be controlled via the electrospinning set-up.  The accelerating voltage 
directly effects the fluid flow from the capillary (56, 64).  As one researcher noted, “the 
changes in the applied voltage will be reflected on the shape of the suspending droplet at 
the nozzle of the spinneret, its surface charge, dripping rate, velocity of the flowing fluid, 
and hence on the structural morphology of electrospun fibers (64).”  The same 
researchers, however, did notice that the accelerating voltage can affect the morphology 
of the fibers that were formed.  This can be seen in Figure 14.   
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Figure 14: The effects of voltage on fiber morphology.  Image taken from (64). 
 
 
 
 Lastly, the pump rate can also affect the electrospinning process.  Generally, the 
pump rate can determine the quality of the fibers that are formed (56, 57, 65).  The pump 
rate, more commonly referred to as the feed rate, affects the quality by altering the 
droplet that forms at the end of the capillary.  This is respect, it is similar to viscosity, but 
the pump rate does not usually affect if fibers are formed or not.  It usually affects only 
the morphology, but there are several examples where this is not the case (56, 57, 65). 
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2.2.2.3 Environmental Parameters 
 Not surprisingly, the environment in which a solution is spun can affect the entire 
electrospinning process.  Of all the parameters discussed, these can be some of the 
hardest to control or alleviate the effects of.  The primary environmental factors that 
affect electrospinning are temperature and humidity. 
 Temperature affects several other parameters in the electrospining process.  The 
temperature mostly affects if a reaction will take place within the spinning solution, the 
vapor pressure of the solvents in the solution, and also the degradation of any temperature 
sensitive polymers (56, 57).  Obviously, temperature plays a huge role in determining 
which polymers and solvents must be used, and how they should be used.  Without it, the 
solution could evaporate before it makes contact with the collector. 
 Finally, the humidity of the environment plays a dramatic role in the 
electrospining process.  The humidity can affect anything from the fiber morphology, the 
pore size of the fibers, or if the fibers (56).  The exact mechanisms behind how humidity 
generates such varying effects are still unknown, and are still being investigated. 
2.3 Applications of Electrospun Fibers and Membranes 
 Needless to say, electrospun fibers have a large amount of possible applications.  
Electrospun fibers and membranes can be used in filtration, clothing, drug delivery, 
biomaterials, tissue engineering, nanotubes, and nanoelectronics (66–72).  Within the 
scope of this study, focus was placed on biomaterials and tissue engineering. 
 Electrospinning has been used in the field of biomaterials for many years.  One of 
the natural advtanges of this process is that the fibrous membrane naturally resembles the 
ECM of most tissues in both size and mechanical properties (67).  As a result, 
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electrospun fibers and mats have become fairly popular, but the most common 
application is in the overlapping field of tissue engineering. 
 Tissue engineering has used electrospinning for almost as long as biomaterials, 
and for the same reason (67).  Electrospun mats and membranes have seen use in 
attempts to tissue engineer bone, nerve cells, and many other tissues (67, 69, 73).  The 
reason why electrospinning was used was because the mats offered a way for the cells to 
attach to a mimicked environment and behave physiologically normal (67, 69, 73). 
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Chapter 3: Experimental Design and Procedure 
3.1 Materials 
The basic materials that were used in this study were: 
Solids: 
 Chondroitin sulfate sodium salt, 90+% purity (Indofine Chemical Company, 
Hillsborough, NJ, 5 gram container) 
 Hyaluronic acid sodium salt (Dali Hyaluronic Acid Company, Liuzhou City, 
Guangxi, China, 1000 gram package) 
 Disodium phosphate, Anhydrous, ≥99.999% (metals basis), (Fluka, St. Louis, 
MO, 100 gram container) 
Liquids: 
 N,N – Dimethylformamide, Anhydrous, 99.8% (Sigma-Aldrich, St. Louis, MO, 2 
Liter bottle) 
 Acetic acid 99.7% (Sigma-Aldrich, St. Louis, MO, 2.5 Liter bottle) 
 Deionized water (Milli-pore Filtration System, Ultra-pure water filter, water 
resistivity: 18.2Ω at 25°C) 
 Divinyl sulfone 97% (Sigma-Aldrich, St. Louis, MO, 25 gram container) 
 
3.1.1 Dimethylformamide Solvent System 
 The first solvent system to be used during this study contained N,N - dimethyl 
formaldehyde (DMF) as one of the primary solvents for ChS and HA.  The procedure for 
creating this solution was taken and modified from a previous study (21, 22).  First 0.6 g 
of HA sodium, 0.2 g ChS sodium salt, and 0.6 g of disodium phosphate were mixed 
together in a glass beaker with a glass stirring rod.  Next, the solids were mixed in a 
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20mL volume of 1:1 DMF and distilled water.  This solution was stirred with a glass 
stirring rod until the polymer completely dissolved into solution.  
3.1.2 Acetic Acid Solvent System 
 The acetic acid (AA) solvent system was made in a similar fashion to the DMF 
system.  For each sample, 0.3 g of HA was used and a varying amount of ChS was used. 
Unlike the DMF samples, the materials in the spun solution were altered depending on 
what was to be examined.  Specifically, the mass of the ChS was varied for each 
experiment.  This data can be seen in Table 2. Once the polymers were thoroughly mixed 
with a glass stirring rod, the polymers were then added to a 6 mL, 1:5 solution of AA: 
distilled water. Once again, the solution was stirred with a glass stirring rod until the 
polymer completely dissolved into solution. 
 
 
 
Table 2: Mass and weight percent of ChS used.  All other masses were held constant. 
Mass of ChS (g) Weight Percent (M/M) of ChS 
0.33 5 
0.69 10 
1.10 15 
1.56 20 
2.68 30 
 
3.1.3 Divinyl Sulfone Crosslinking 
 DVS crosslinking was attempted on both the DMF and AA solvent systems in 
order to compare them on a one-for-one basis.  Such a comparison would determine 
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which solution would be the best for a biomimetic type device.  A low concentration for 
both polymers was chosen so as to be more economical.  Calculations were performed to 
determine the ideal amounts of polymer and DVS that would be needed using the number 
of moles of each substance.  It was shown, however, that given the different molecular 
weights of the polymers, mathematically there would always be an excess of one 
polymer.  For solutions with an excess of ChS the amount of moles used was 4.30x10
-4
 
moles, and for solutions with an excess of HA the amount of moles used was 5.30x10
-4
 
moles.  These calculations can be seen in Appendix A.  Both solvent systems were mixed 
in the same ways as previously, but DVS was added simultaneously with the aqueous 
solvents attempting to electrospin.  Once again, the solution was stirred with a glass 
stirring rod until the polymer completely dissolved into solution. 
3.2 Electrospinning 
 The electrospinning apparatus consisted of a syringe pump (Harvard Apparatus, 
70-2209, Holliston, MA), a high voltage power supply (Gamma High Voltage Research, 
ES60P-10W, Ormond Beach, FL), a 10mL syringe (Becton, Dickinson and Company , 
REF309604, Franklin Lakes, NJ), and a 21 or 16 guage Luer-lock needle (both Becton, 
Dickinson and Company , 305165 and 305198 respectively, Franklin Lakes, NJ).  An 
image of the apparatus can be seen in Figure 15. 
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Figure 15: Photograph of the electrospinning set-up that was used in this experiment.  
On the lower left is the syringe pump.  Loaded on to the syringe pump is a 10 mL syringe 
with a 16 gauge needle attached.  The needle is connected the high voltage supply (top 
right). 
 
 
 
3.2.1 Dimethylformamide Solvent System 
 The polymer solution was electrospun with several parameters being studied for 
each trial.  The control for this study was based on the previous work from (21, 22).  
Specifically, the control solution was electrospun at a distance of 7 cm, with an 
accelerating voltage of 17 kV, and a pump rate of 5 μL/min.  All samples were allowed to 
spin for 15 minutes.  Table 3 shows the variables that were changed for each sample in 
each trial.  Please note that both the temperature, and relative humidity in the 
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environment during electrospinning were recorded using a digital thermohygrometer 
(Cole-Palmer, RH520A, Vernon Hills, IL). 
 
 
 
Table 3: The recorded electrospinning parameters and variables for each sample.  The 
accelerating voltage, distance between the syringe tip and collector plate was recorded, 
pump rate, and electric field were recorded for all 13 samples.  
Sample Conditions 
Voltage 
(kV) 
Distance 
(cm) 
Rate 
(µL/min) 
Electric 
Field 
(kV/cm) 
Temp 
(°C) 
RH 
(%) 
0 No NaPO4 17 7 5 2.4 23 22 
1 
Control 
Constant 
Field 
17 7 5 2.4 22 22 
2 
Constant 
Field 
21 9 5 2.4 22 22 
3 
Constant 
Field 
27 11 5 2.4 22 22 
4 
Varied 
Voltage 
15 7 5 2.1 22 22 
5 
Varied 
Voltage 
12 7 5 1.7 22 22 
6 
Varied 
Voltage 
9 7 5 1.3 22 22 
7 
Varied Pump 
Rate 
17 7 7 2.4 22 22 
8 
Varied Pump 
Rate 
17 7 3 2.4 22 22 
9 
Varied Pump 
Rate 
17 7 1 2.4 22 22 
10 
Varied 
Distance 
17 5 5 3.4 22 22 
11 
Varied 
Distance 
17 9 5 1.9 22 22 
12 
Varied 
Distance 
17 11 5 1.5 22 22 
 
3.2.2 Acetic Acid Solvent System 
Similar to the DMF system, all AA systems were electrospun at a distance of 7 
cm, with an accelerating voltage of 17 kV, and a pump rate of 5 μL/min.  All samples 
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were allowed to spin for 30 minutes in order to allow for a large quantity of fibers.  See 
Table 4 for a breakdown of the spin conditions at the time of experiment.   
 
 
 
Table 4: Summary of the AA solvent system solutions that were spun and the atmospheric 
conditions on that day.   
Weight Percent of  ChS 
(wt% [m/m]) 
Temp 
(°C) 
RH (%) 
1 20.0 24 
5 22.2 22 
10 22.2 74* 
15 22.2 69* 
20 22.2 22 
30 22.8 26 
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3.3 Measuring pH 
 The pH was taken using a pH paper (VWR North American, BDH35309.606).  
Images of the equipment can be seen in Figure 16. 
 
 
 
 
Figure 16: The pH paper used in this experiment. 
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3.4 Viscosity 
 The viscosity of all samples was determined using either an Ubbelohde glass 
viscometer (UGV) (Fisher Scientific, 13-614A, Pittsburgh, PA), or a rheometer (TA 
Instruments AR Rheometer) as can be seen in Figure 17.  The UGV measures the 
kinematic viscosity of the polymers.  The kinematic viscosity was calculated using 
ASTM D 445 standards.   The kinematic viscosity was then converted to relative 
viscosity.  The capillary diameter of the UGV was 1 mm.  Each solution was measured 
three times in order to get an average kinematic viscosity at 22 – 23 °C (the operating 
limit for the UGV was 22 ± 2°C).  The UGV could only measure kinematic viscosity 
from 2 cSt to 10 cSt. 
Additionally, a rheometer (TA Instruments AR Rheometer) was used for solutions 
that were either too viscous, or not viscous enough, to be measured in the UGV.  The 
conditions used were a temperature of 25 °C and a 40 mm circular parallel plate, with a 
shear rates ranging from 0 – 300 s-1.   The rheometer recorded the dynamic viscosity in 
Pa*s.  This was converted to kinematic viscosity (cSt) so as to allow for a comparison 
with the DMF solutions, and then to relative viscosity for the same reason.  Unlike the 
kinematic viscosity, the dynamic viscosity does not take the density of the solution into 
consideration, thus a conversion was needed in order to perform a comparison.  The 
viscosity that was recorded was averaged from several points according to when the shear 
stress was near zero in order to obtain a near-zero viscosity, which in theory remains 
constant (8).  This procedure was adapted from a previous study (8). 
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Figure 17: The instruments used to measure viscosity.  Top) The UGV, Bottom) the 
rheometer. 
  
38 
 
 
3.5 Attenuated Total Reflectance Fourier Transform Infrared Spectroscopy 
 Attenuated total reflectance Fourier transform infrared spectroscopy (ATR-FTIR) 
was performed to determine if any mats contained both HA and ChS.  Specifically, ATR-
FTIR (Thermo Scientific, Nicolet Nexus 870 FT-IR Spectrometer, Waltham, MA.) had a 
temperature controller that ranged from 22-110°C (22°C was used), could measure near 
and mid infrared, and also contained the single bounce ATR accessory.  The ATR-FTIR 
was used to examine the percent absorption peaks from 3500 cm
-1
 to 500 cm
-1
.  The 
device can be seen in Figure 18. 
 
 
 
 
Figure 18: Image of the AT-FTIR that was used in this study. 
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3.6 Field Emission Scanning Electron Microscopy 
 Field emission scanning electron microscopy (FESEM, Zeiss Supra 50VP) was 
used to determine if fibers were successfully electrospun, and to determine the diameters 
of the spun fibers. All samples were mounted on a stub using a double-sided carbon tape 
then coated with platinum/palladium for 35 s, 40 mA using Denton vacuum desk II 
sputtering machine.  This was done to improve the charging on the samples.  See Chapter 
4 for a detailed breakdown for each SEM images. See Figure 19 for an image of the 
SEM. 
 The FESEM images were analyzed using ImageJ software from the US National 
Institutes of Health.  This program uses Java programming in order to perform image 
enhancement and measurement (74).  This software is open source and available to the 
public.  ImageJ was used to measure the diameter of the fibers.  For each sample, 50 
fibers were measured.  This was done to ensure a large statistical population. 
 
 
 
 
Figure 19: Image of the type of SEM that was used in this experiment (75). 
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3.7 Energy-Dispersive X-ray Spectroscopy 
 Energy-dispersive x-ray spectroscopy (EDX) was used to determine if both ChS 
and HA were in specific electrospun fibers.  Specifically, since ChS contained a sulfate 
group, the EDX would confirm that ChS was in a fiber because it is the only component 
that would contain such a group.  EDX was done in conjunction with, and in support of, 
FTIR.  The EDX operates as an attachment to the SEM.  The EDX device was from 
Oxford Energy-Dispersive X-ray Microanalysis. 
3.8 Solubility 
Solubility testing was performed to determine how well an electrospun mat would 
survive in an aqueous environment.  This was performed using three different aqueous 
baths: one bath contained 20 mL of 1.0M of acetic acid, another contained 20 mL of 
1.0M sodium hydroxide, and the last bath contained 20 mL of distilled water (38).  Six 
samples (each sample was 1 mm
2
 in area) were prepared, such that each bath would 
contain two samples.  One of each sample was immersed in the baths for 15 minutes and 
72 hours respectively (38).  After the appropriate amount of time, the solution was 
examined for any change in transmittance.  Transmittance at 600 nm as taken using the 
reflectance spectrometer seen in Figure 20 (Ocean Optics, Inc., USB2000 Miniature Fiber 
Optic Spectrometer, and DH-2000 Deuterium Tungsten Halogen Light Sources, Dunedin, 
FL) (38). 
The solubility was determined by the transmittance of the bath liquids.  Cuvettes 
filled with 1.5 mL of sample from each bath were used.  The transmittance of the samples 
was compared to that of control baths.  If the sample had a transmittance from 80 - 90%, 
the sample was dissolving (38).  If the sample had a transmittance greater than 90%, and 
there was no visual confirmation, the sample has dissolved (38).  If the sample’s 
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transmittance was above 90%, and there was visual confirmation of the sample, then the 
sample was still dissolving (38).  If any samples were below 80%, they were considered 
to be not dissolving (38). 
 
 
 
 
Figure 20: Image of the reflectance spectrometer set-up used to characterize the 
solubility of the samples. 
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Chapter 4: Results and Discussion 
4.1 Dimethylformamide Solvent System 
The DMF systems had multiple successful electrospin mats.  As mentioned 
previously, two different solutions were tested.  The general parameters are seen below in 
Table 5. 
 
 
 
Table 5: Summary of the pH of the DMF solutions examined 
Solution pH 
NaPO4 7 
No NaPO4  7 
 
 
 
4.1.1 Viscosity 
 The viscosity profiles of the solutions were unsurprising.  On average, there was 
an increase in viscosity with increasing amounts of polymer solution.  This is consistent 
with literature (76, 77).  The 1 wt% ChS with 2 wt% HA in DMF co-polymer system was 
not tested because it was not observed to flow once placed in the UGV.  Furthermore, 
time constraints prevented a rheological exam. 
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Figure 21: Viscosity of the DMF solvent systems with each polymer. 
 
 
 
What is interesting, however, is the difference between the addition of ChS and 
HA individually to the solvent system.  As can be seen in Figure 21, the relative viscosity 
of ChS was only 1.04 ± 0.01.  The average kinematic viscosity was 0.10 ± 0.01 cSt.  This 
viscosity for the ChS is to be as expected.  A previous study determined that for the 
weight percent of ChS that was used, the average kinematic viscosity was approximately 
0.09 cSt (78).  This value is very close to what was expected.        
Another trend was observed with the HA sample.  Although data were recorded, it 
was beyond the viscometer’s accuracy.  The UGV used could only measure up to 10 cSt, 
while the lowest HA value was 55.38 cSt.  It is safe to say that the solution with only HA 
is more viscous than the ChS solution.  The kinematic viscosity recorded for the HA 
sample is  close to the lower end of the reported range of 50 – 1000 cSt that was been 
recorded in other studies (79, 80).  What data that was able to be obtained from this 
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experiment suggests that the HA being used is of lower purity due to ultrapure HA 
having a kinematic viscosity of approximately 1000 cSt (79, 80). 
4.1.2 Attenuated Total Reflectance Fourier Transform Infrared Spectroscopy 
 The IR spectroscopy data of the DMF solvent system fibers reveal that ChS is 
present in the fibers.  As can be seen in both Figure 22 and Figure 23, the IR spectrum for 
the ChS and HA mat contain the same key peaks that are found in the bulk HA and ChS 
peaks.  The key characteristic peak for ChS, specifically Ch4S, is found at 848 cm
-1
 (9, 
81).  These can be seen below in Table 6. 
All IR spectra for this solution were taken using the Na2PO4 solution.  This was 
done because it had the largest fibers overall, and as a result would most yield a more 
defined spectrum.  Furthermore, it was used because the majority of the mats used during 
this part of the study were those containing Na2PO4. 
 
 
 
Table 6: Key peaks for both ChS and HA.   
Peak Wavenumber (cm
-1
) Species 
848 ChS Characteristic Peak: C–O–S (9, 81) 
1396 C-O (21) 
1633 C=O/C-N (21) 
2800-2900 C-H (21) 
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Figure 22: IR spectra of ChS+HA fibers for the DMF solvent system as compared to the 
bulk polymers ChS and HA.   
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Figure 23: IR spectra for the DMF solvent system as compared to the bulk polymers; 
focused from 2500 cm
-1
 to 600 cm
-1
. 
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4.1.3 Field Emission Scanning Electron Microscopy 
As can be seen in both Table 7 and Table 8, fibers were produced using the DMF 
solvent system.  The diameters of the fibers varied greatly depending on the spin 
conditions. In both Figure 24 and Figure 25, there appears to be a general trend with the 
data.  For example, all samples that had a constant field showed an increasing linear trend 
despite both the voltage and the distance were increased. 
 
 
   
Table 7: Summary table of SEMs and Histograms of fiber diameters for the DMF 
optimization study. 
Sample SEM Image Histogram of Fiber Diameters 
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Figure 24: Summary of all fiber diameters.  Purple indicates no NaPO4, Yellow indicates 
a constant field, Blue represents a change in voltage, Red indicates a change in pump 
rate, and Green represents a change in distance. 
 
 
 
 
Figure 25: Graph comparing the effect of voltage on fiber diameter. 
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Figure 26: Graph comparing the effects of distance on fiber diameter. 
 
 
 
 
Figure 27: Graph comparing the effects of the electric field on the fiber diameters. 
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Figure 28: Graph comparing the effects of pump rate on fiber diameter. 
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Table 8: A summary table of the fiber diameter statistical data from Figure 24, the 
statistical sample size was 50 except for Sample 9 which had a sample size of 10. 
Sample Conditions Mean (µm) 
St. Dev. 
(±µm) 
Max (µm) Min (µm) 
0 No NaPO4 0.046 0.015 0.083 0.013 
1 
Constant 
Field 
0.068 0.033 0.187 0.024 
2 
Constant 
Field 
0.094 0.039 0.184 0.030 
3 
Constant 
Field 
0.116 0.040 0.218 0.043 
4 
Varied 
Voltage 
0.104 0.039 0.227 0.048 
5 
Varied 
Voltage 
0.098 0.034 0.182 0.039 
6 
Varied 
Voltage 
0.185 0.077 0.377 0.074 
7 
Varied 
Pump Rate 
0.129 0.044 0.236 0.048 
8 
Varied 
Pump Rate 
0.126 0.040 0.218 0.068 
9 
Varied 
Pump Rate 
0.203 0.069 0.307 0.103 
10 
Varied 
Distance 
0.102 0.044 0.240 0.044 
11 
Varied 
Distance 
0.105 0.042 0.220 0.031 
12 
Varied 
Distance 
0.190 0.086 0.373 0.056 
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The reasons for this are because the field was maintained constant.  To put it 
simply, the electric field aids in creating the initial instability in the polymer solution that 
eventually results in the jets that create the polymer fibers (50, 82, 83).  In the case of this 
experiment, since the field was kept constant, fibers would always be produced.   
The increasing fiber diameter is the result of the increasing distance (65).  When 
the voltage of a system is kept constant, but when the distance is not, it is possible that 
the polymer solution will not be stretched as thinly (65).  Although this previous study 
was not examining the effect of the electric field on the fiber diameter, the same principle 
applies.  To summarize, the further away from a target the solution is, the more voltage is 
required to spin successfully.  This also helps to explain some of the linear behavior seen 
in the samples where the distance was increased, but with no change in voltage.  These 
conclusions are supported by the data shown in both Figure 26 and Figure 27. 
As the name would suggest, the behavior seen in the sample set where the voltage 
was changed was due to the change in voltage.  As noted earlier, a change in voltage can 
severely affect the size and morphology of the fibers (56, 64, 65).  For Sample 6 
specifically, the drastic change in fiber diameters suggests that the voltage change created 
more instability in the fibers than was necessary, and as a result led to the fibers being 
larger than the others.  This conclusion is supported by data shown in Figure 25. 
Furthermore, the change in pump rate was the main reason for the behavior in the 
sample set where the pump rate was varied.  Although pump rate usually does not 
drastically affect fiber morphology, this was not the case in this experiment (59, 65, 84).  
Under certain circumstances, the pump rate can affect fiber diameter and morphology 
(56, 64, 65).  As the rate was lowered, less polymer solution was available on the needle 
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tip to spin which explains the overall low yield of this series.  As can be seen in Figure 
28, there does not appear to be a trend associated with altering the pump rate. 
4.2 Acetic Acid Solvent System 
 The pH data for each sample can be seen in Table 9.  The data showed that on 
average the solutions were acidic in nature.  However, it appeared that ChS did make the 
solution more basic in the higher concentrations.  This solvent system was spun at a 
voltage of 15 kV, 7 cm distance, and with an infusion rate of 5 uL/min.  Other distances 
and voltages were attempted, but these yielded no fibers.  Data for those attempts can be 
seen in Appendix B. 
 
 
 
Table 9: The pH for each different wt% of ChS. 
ChS (wt %) pH 
5 3 
10 3 
15 4 
20 4 
30 4 
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4.2.1 Viscosity 
 The viscosity measurements of the AA solutions follow the expected trend for 
such a system.  As can be seen in Figure 29, the viscosity of the solution decreased with 
increasing amounts of ChS.  This is to be expected as it is known that at room 
temperature in a non-alkaline solution, the viscosity number of ChS is 41 (85).  This 
indicates that beyond a certain mass, the system will become oversaturated and the 
viscosity will drop (85).  This is due to less entanglement from the polymers (78, 85).  
The data supports this assertion.  The relative viscosities of the solutions were 253,029 ± 
8.08 for the HA sample, 198,478 ± 5.94 for the 1wt% ChS sample, and 32,129 ± 0.36 for 
the 5wt% ChS sample.  Compared to the DMF solutions, these solutions were generally 
more viscous due to the larger relative viscosity that is exhibited in these solutions.  
 
 
 
 
Figure 29: Graph showing the viscosity of the lower weight percents for the AA solvent 
system.  Please note the mass of HA was held constant throughout. 
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4.2.2 Attenuated Total Reflectance Fourier Transform Infrared Spectroscopy 
 FTIR of the electrospun fibers confirmed that both HA and ChS were found in the 
mat.  As can be seen in both Figure 30 and Figure 31, the IR spectrum for the ChS and 
HA mat contain the same key peaks that are found in the bulk HA and ChS peaks.  The 
key characteristic peak for ChS, specifically Ch4S, is found at 854 cm
-1
 (9).  Given the 
similarities in functional groups, both HA and ChS have similar peaks.  These can be 
seen below in Table 10. 
 All IR spectra for this solution were taken using the 30 wt% ChS solution.  This 
was done because it had the largest fibers overall, and would most yield a more defined 
spectrum. 
 
 
 
Table 10: Shared peaks between ChS and HA.   
Peak Wavenumber (cm
-1
) Species 
848 ChS Characteristic Peak: C–O–S (9, 81) 
1396 C-O (21) 
1633 C=O/C-N (21) 
2800-2900 C-H (21) 
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Figure 30: IR of the bulk ChS, bulk HA, and 30% mass ChS mat. 
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Figure 31: IR spectra for the range of 2500-600 showing the key peaks for the polymers. 
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4.2.3 Field Emission Scanning Electron Microscopy 
 The SEM images of the electrospun fibers yielded fascinating results.  Only the 
samples that were subjected to the concentration study were examined using the SEM.  
To begin, all polymer solutions that were tested successfully spun fibers.  The images and 
statistics of each sample can be seen in Tables 11 & 12. 
 
 
 
Table 11: Summary table of SEM images and histograms. 
Sample SEM Image Histogram of Fiber Diameters 
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Table 12: Summary data for the fiber diameters for the AA solvent system.  Same data as 
found in Figure 32. 
Percent % of 
ChS 
Average 
(μm) 
St. Dev. 
(±μm) 
Max 
(μm) 
Min 
(μm) 
5 0.08 0.03 0.16 0.012 
10 2.04 0.89 4.63 0.61 
15 3.75 2.74 17.47 0.75 
20 6.31 2.75 14.42 2.00 
30 11.97 14.89 82.96 3.86 
 
 
 
The SEM images for the AA solution systems revealed a very surprising trend.  
As can be seen in both Figure 32 and Figure 33, there was a general increase of fiber 
diameter of nearly 2-3 times for each increase in the weight percent of ChS.  Although, 
this would seem to be in defiance of the general rule of, “increased concentration, 
decreased fiber diameters,” this is not the case.  As noted earlier, there is evidence to 
suggest that the increase in concentration will lead to an increase in fiber diameter (56, 
64, 65).  As the only variation between these samples was the concentration of ChS, it is 
very likely that the concentration of ChS caused an increase in the fiber diameters. 
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Figure 32: Summary of fiber diameters for the AA solvent system. 
 
 
 
 
Figure 33: Fiber diameters for the samples demonstrate a linear trend in conjunction 
with an increase of ChS. 
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Additionally, as can be seen in Figure 33, the relationship between polymer 
concentration and fiber diameter is very linear.  A linear regression was performed on the 
data that confirmed this suspicion.  This behavior lends further support to the theory that 
an increase in concentration will lead to increased fiber diameters.   
Finally, the viscosity and concentration of these solutions could explain the 
increased fiber diameters.  Previous studies noticed that there was a correlation between 
fiber diameters, concentration, and viscosity (86, 87).  One researcher did notice that 
viscosity had a small effect on fiber size due to a longer polymer jet (87).  The 
researchers speculated that because the polymer jet was more elongated in higher 
viscosity solutions which would lead to smaller diameter polymers (87).  The researchers 
concluded that concentration had a greater effect on electrospin fibers (87). 
Furthermore, as mentioned earlier, an increase in the concentration of ChS can 
lead to less entanglement of the polymer chains due to oversaturation (78, 85).  This 
could also explain the larger fiber diameters since the polymers were not as entangled as 
others, but were beyond the critical entanglement point. 
4.2.4 Energy-Dispersive X-ray Spectroscopy 
 EDX scans of the 30wt% ChS sample further confirmed that ChS was in the 
sample fiber in addition to HA.  As HA has been known to spin very well, it was assumed 
that HA was already present in the fibers, or was the only compound to spin (21, 22).  
FTIR did confirm that ChS was present in mat, but it could not determine if ChS was 
actually in the fiber.  As can be seen in Figure 34, EDX did show that sulfur was in the 
fibers.  The image used to acquire these scans can be seen in Figure 35.   
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Figure 34: EDS scan of fibers found in the 30% mass ChS sample with background 
elements removed. 
 
 
 
 
Figure 35: Image used in the EDX scan.  Image is another view of the 30 wt% ChS 
solution. 
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4.3 Chemical Stability 
 The DVS crosslinked solutions yielded some surprising results.  As the DMF 
solution without Na2PO4 was found to be among the best of the DMF solutions due to the 
fewer materials required, and the smallest fibers, this was used as basis for the testing 
solution for the DMF species.  The 5 wt% ChS AA solution was used as the starting point 
for the AA solutions with DVS.  As noted previously, four solutions were used in this 
part of the study.  The pH of these solutions can be seen below in Table 13. 
 
 
 
Table 13: The pH of the DVS crosslinker solutions. 
Solution 
pH 
DMF Excess HA 6 
DMF with Excess ChS 6 
AA with Excess HA 
4 
AA with Excess ChS 
4 
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4.3.1 Field Emission Scanning Electron Microscopy  
 The DMF-DVS systems contained one of the best SEM images.  The best image 
was from the sample that contained excess HA.  The solution containing excess ChS 
failed to spin properly and as a result no SEM was performed.   
 
 
 
 
Figure 36: SEM image of the fibers produced from this solution (top) and a histogram 
with table containing the statistical analysis of the fiber diameters (bottom). 
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The fibers that were spun prior to the cross-linking step were very good.  As can 
be seen in Figure 36 above, the fibers have excellent morphology and have an average 
fiber diameter of 88.89 ± 32.32 nm.  The largest fiber diameter was 187.92 nm, while the 
smallest fiber diameter was 25.00 nm. 
 
 
 
 
Figure 37: SEM image of the fibers produced from this solution (top) and a histogram 
with table containing the statistical analysis of the fiber diameters (bottom). 
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The fibers that were spun after the cross-linking step were drastically altered.  As 
can be seen in Figure 37 above, the fibers appear to have either bonded together, or have 
become swelled due to the water bath that was used to remove excess salt.   Given that 
the average diameter of the remaining fibrous structures was 6.78 ± 2.61 µm, and the 
largest fiber diameter was 11.97 µm, while the smallest fiber diameter was 2.22 µm, the 
swelling choice appears to be correct.  The fibers grew approximately 7000% from the 
start of the cross-linking process to the end. 
Despite this large jump, this is not a bad thing.  The crosslinked “fibers” very 
closely match the natural structure of human cartilage.  In fact, this accidentally 
discovered structure is ideal for a biomimetic device. 
4.3.2 Attenuated Total Reflectance Fourier Transform Infrared Spectroscopy  
The IR spectra of the excess HA fibers, as seen in Figure 38, show a successful 
crosslinking.  There is a clear change in the peaks at 2912 and 2848 which indicates a 
change in the C-H bonds (88).  Furthermore, the change in C=C appears at 1643 could 
indicate that the vinyl groups on DVS have become less prominent, and suggests that the 
crosslinking mechanism may have worked (88).  Although it does not show definitive 
proof of a successful crosslinking step, the IR does offer some support to the theory that 
the polymers were successfully crosslinked.  Table 14 contains the peak wavenumbers. 
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Table 14: IR Peaks for Figure 38. 
Peak Wavenumber (cm
-1
) Species 
848 ChS Characteristic Peak: C–O–S (9, 81) 
1396 C-O (21) 
1633 C=O/C-N (21) 
2800-2900 C-H (21, 88) 
 
 
 
 
 
Figure 38: IR spectra for the excess HA fibers.  Before and after crosslinking are shown. 
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4.3.3 Solubility 
 The solubility test performed on the DMF-HA sample yielded some surprising 
results.  After 15 minutes, the mats were almost completely dissolved in the acidic and 
water baths.  The transmittance values at the 15 minute mark confirm that the mats were 
dissolving at that time (Table 15).  At the 72 hour mark, there was no visible trace of any 
mat.  All transmittance values indicated that the mats had dissolved into solution.   
 The results of this experiment concur with findings in literature.  Although, it 
should be pointed that there is little data available that relates to the solubility of 
crosslinked ChS and HA in the same material; there is a plethora of information, 
however, for each polymer crosslinked individually.  The data that most closely matches 
the behavior observed in this experiment is seen in several studies that examine the 
solubility of crosslinked HA.  The researchers found that crosslinked HA will dissolve 
rapidly when exposed to hydroxyl radicals (89, 90).  In one study, the crosslinked HA 
was dissolved within minutes of being exposed to hydroxyl radicals (90).  
 
 
 
Table 15: Results of the solubility test. 
 
15 minutes 72 hours 
Solution 
Visual  
Observation 
T600 Comments 
Visual  
Observation 
T600 Comments 
1.0 M AA 
Reference 
N/A 99.17 ± 0.39 Control N/A 98.46 ± 1.97 Control 
1.0 M AA No 99.33 ± 1.15 Dissolved No 95.56 ± 0.72 Dissolved 
1.0 M NaOH 
Reference 
N/A 98.53 ± 1.63 Control N/A 98.63 ± 1.43 Control 
1.0 M NaOH Yes 88.38 ± 0.65 
Partially 
Dissolved  
No 92.11 ± 0.05 Dissolved 
DI Water Reference N/A 98.44 ± 0.68 Control N/A 100.13 ± 0.09 Control 
DI Water Yes 101.47 ± 1.20 
Partially 
Dissolved  
No 101.30 ± 0.47 Dissolved 
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Chapter 5: Conclusions 
 First, ChS-HA nanofibers were successfully electrospun using the previously 
known method to electrospin HA.  Secondly, a predominantly ChS mat was successfully 
electrospun using an AA solvent system which may be better for the body than a DMF 
based system.  Finally, it was shown that despite its promise, the AA system did not spin 
with the added crosslinking agent, but the DMF system was spun and crosslinked 
successfully.   
 The DMF based solvent system operated far better than anticipated.  The solution 
spun extremely well in the ideal conditions of room temperature and low humidity.  
Additionally, it was discovered that the DMF solvent system could be spun without 
disodium phosphate, an additive that is required in the spinning of HA.  In an industrial 
application, this would be an excellent advantage as it would drive down the cost of 
manufacture.  Once this solution was identified, the viscosity of the solution, and its pH, 
were determined in order to better understand the solution parameters.   
 The ability to spin the AA system in a lower volume solution was another result 
that was unexpected. As a result, an attempt was made to discover the most ChS that 
could be spun successfully and it was discovered that  larger concentrations of ChS 
produces larger fiber diameters.  
 After some calculations, it was decided to test each system against each other 
using DVS to crosslink the fibers.  This would create a common ground for both solvent 
systems and allow for one on one comparison.  The optimal amounts of polymer were 
added to their respective solvents, and electrospun.  The only solvent system that 
successfully electrospun was the DMF based solution that contained an excess mass of 
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HA which was subsequently tested using solubility tests. In conclusion, this study 
successfully laid the groundwork for the development of an electrospun biomimetic 
scaffold for both human cartilage and knee meniscus.  There is much more work to be 
done in regard to these systems, but this study has shown that with some refinement, two 
different systems can work can be used to accomplish this goal.      
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Chapter 6: Future Work 
6.1 Collagen 
 As noted previously, collagen is the primary polymeric material by mass in both 
the knee and cartilage.  Future direction will be to include collagen into the CS-HA 
crosslinked fibrous mats. The reason that collagen was not spun in this study was because 
it is known to cause scar tissue formation, and possibly cause an immune system reaction 
(21). Collagen should provide mechanical strength that is needed for this biomimetic 
scaffold to function properly in the human body. 
6.2 Mechanical Testing  
 The mechanical testing of this biomimetic scaffold should be attempted in the 
future.  One of the primary reasons why mechanical testing was not performed during 
this study was that collagen was missing from the scaffold.  Without collagen, it is 
unlikely that the electrospun fibers would have matched the natural tissue in any form of 
mechanical testing.  Given the discovered structural properties of the electrospun and 
crosslinked fibers, however, this should not be a challenge to future researchers. 
6.3 Cell and Clinical Studies 
 As with all devices that will be inserted into the human body, cellular studies 
must be performed on the device.  Such a study will be able to definitively prove which 
solvent system will be the best for a biomimetic scaffold.  Hopefully, such tests will lead 
to a new medical device on the market for the treatment of OA.  
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Appendices 
Appendix A: Equations used to calculate the optimal amount of DVS to be used 
  
 
 
 
The moles for each polymer were calculated using the following equation: 
                                                     Eq.1 
The results of this calculation are seen below in Table 16.  The mass of all components 
was 0.2 g to start off.  Any mass could have been used, but 0.2 g was used because it 
would translate to a low weight percent. 
 
 
 
Table 16: Results of Eq.1. 
Chemical Mass (g) Density (g/mL) Mw (g/mol) Moles 
ChS 0.2 - 463 0.00043 
HA 0.2 - 379 0.00053 
DVS 0.2 1.17 118.1 0.00169 
 
 
 
Once the number of moles had been determined, it was realized that there would always 
be an excess of one polymer compared to the other.  With this in mind, the Solver tool in 
Microsoft Excel 2010 was used to back calculate the ideal mass for a polymer and DVS, 
using the other polymer as the reference.  The Solver tool used a GRG nonlinear 
mathematical modeling to return the correct mass that would be needed to crosslink all 
moles of polymer with DVS.  A screenshot of Solver can be seen in Figure 39.  The 
results of Solver can be seen in Table 17. 
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Table 17: Results of the solver tool.  As can be seen, the mass of each chemical correctly 
correspond to the moles used for each sample. 
Moles ChS as the Starting Point 
Chemical Mass (g) Density (g/mL) Mw (g/mol) Moles 
ChS 0.20 - 463 0.00043 
HA 0.16 - 379 0.00043 
DVS 0.03 1.17 118.1 0.00043 
Moles HA as the Starting Point 
Chemical Mass (g) Density (g/mL) Mw (g/mol) Moles 
ChS 0.24 - 463 0.00053 
HA 0.20 - 379 0.00053 
DVS 0.03 1.17 118.1 0.00053 
 
 
 
 
 
 
Figure 39: Screen shot of the solver tool in use. 
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Appendix B: Previous Attempts to Electrospin the AA solvent system 
  
 
 
 
Table 18: The same procedure used for the DMF solvent system was used.  The only 
solution that worked was at 15 kV, highlighted in yellow.  The fiber diameter is recorded 
for that sample in the far right column. 
Conditions Voltage 
(kV) 
Distance 
(cm) 
Rate 
(µL/min) 
Electric 
Field 
(kV/cm) 
Temp 
(°C) 
RH 
(%) 
Fiber Diameter 
(µm) 
Constant 
Field 
17 7 5 2.4 24 22 - - 
Constant 
Field 
21 9 5 2.4 24 22 - - 
Constant 
Field 
27 11 5 2.4 24 22 - - 
Varied 
Voltage 
15 7 5 2.1 24 22 0.398 ± 0.147 
Varied 
Voltage 
12 7 5 1.7 24 22  
 
Varied 
Voltage 
9 7 5 1.3 24 22 - - 
Varied 
Pump Rate 
17 7 7 2.4 24 22 - - 
Varied 
Pump Rate 
17 7 3 2.4 24 22 - - 
Varied 
Pump Rate 
17 7 1 2.4 24 22 - - 
Varied 
Distance 
17 5 5 3.4 24 22 - - 
Varied 
Distance 
17 9 5 1.9 24 22 - - 
Varied 
Distance 
17 11 5 1.5 24 22 - - 
 
